// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























1151 Abstracts

Reducing Cardiovascular Risk with Immunomodulators: A Single Blind Randomized Active Comparator Trial Among Patients with Rheumatoid Arthritis

Daniel Solomon - American College of Rheumatology (ACR) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

Safety Profile of Hydroxychloroquine in a Large Cohort of Rheumatology Patients Within the US Department of Defense Military Healthcare System

Toni Rush - American College of Rheumatology (ACR) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

SARS-CoV-2 mRNA Vaccine Immunogenicity in Chronic Inflammatory Arthritis on DMARD Therapy

Nedal Darwish - American College of Rheumatology (ACR) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

Hydroxychloroquine

Severe Non-adherence to Hydroxychloroquine Is Associated with Flares, Early Damage, and Mortality in Systemic Lupus Erythematosus: Data from 660 Patients from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

Yann Nguyen - American College of Rheumatology (ACR) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Lupus

Hydroxychloroquine

The Collaborative National Quality and Efficacy Registry for Scleroderma: Association of Medication Use on Gastrointestinal Tract Symptoms in Early Disease

Sarah Luebker - American College of Rheumatology (ACR) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

Hydroxychloroquine

The Effect and Outcomes of HCQ Alone and in Combination with Anti-Depressants on QTc

Kourtney Rudzinski - American College of Rheumatology (ACR) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

Therapeutic Thresholds of Hydroxychloroquine Blood Levels: Physiologic and Social Determinants of Low Hydroxychloroquine Blood Levels

Shivani Garg - American College of Rheumatology (ACR) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

Time to First Remission and Prevalence of Sustained Remission After Etanercept Biosimilar (ETA-B) or Originator (ETA-O) Initiation in Rheumatoid Arthritis

Sasha Bernatsky - American College of Rheumatology (ACR) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

Use of Biologic or Targeted Synthetic Disease Modifying Anti-rheumatic Drugs and the Risk of Lymphoma in Rheumatoid Arthritis

Namrata Singh - American College of Rheumatology (ACR) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

Use of Disease Modifying Anti-rheumatic Drugs and Risk of Multiple Myeloma in US Veterans with Rheumatoid Arthritis

Namrata Singh - American College of Rheumatology (ACR) , 2022

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

Inappropriate Sinus Tachycardia and 18 FDG PET Scan

Nourhan Chaaban - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Antiphospholipid syndrome

Hydroxychloroquine

The Effects of Hydroxychloroquine on Electrocardiogram Intervals

Ahlam Alawadhi - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

Hydroxychloroquine

Libman-Sacks Endocarditis Mimicking Intracardiac Tumor in a Patient With Systemic Lupus Erythematosus and Secondary Antiphospholipid Syndrome

Dayana Orozco -Sepulveda - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Lupus

Hydroxychloroquine

MYOPERICARDITIS WITH CARDIAC TAMPONADE AS AN INITIAL PRESENTATION OF LUPUS IN A 23-YEAR-OLD MAN

Hank Davis - American College of Cardiology (ACC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Lupus

Hydroxychloroquine

PREVALENCE OF ECG TESTING AND CHARACTERISTICS AMONG NEW HYDROXYCHLOROQUINE AND CHLOROQUINE PRESCRIPTIONS WITHIN A LARGE MULTI-CENTER TERTIARY CARE CENTER

Brittany Weber - American College of Cardiology (ACC) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

AMYLOID MIMICS: REMEMBERING HYDROXYCHLOROQUINE CARDIOMYOPATHY

Antoinette Birs - American College of Cardiology (ACC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Left ventricular hypertrophy

Hydroxychloroquine

CHALLENGES IN THE MANAGEMENT OF MIXED CONNECTIVE TISSUE DISEASE-ASSOCIATED PULMONARY HYPERTENSION AND CARDIOGENIC SHOCK

Laura Neubauer - American College of Cardiology (ACC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Pulmonary arterial hypertension

Hydroxychloroquine

LUPUS MYOCARDITIS PRESENTING AS AN INFERIOR STEMI IN A 17-YEAR-OLD

Maulin Patel - American College of Cardiology (ACC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

PERICARDIAL EFFUSION AS AN EARLY FINDING OF CONNECTIVE TISSUE DISEASE

Fedoua Er Rbii - American College of Cardiology (ACC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Raynaud syndrome

Hydroxychloroquine

A RARE ENTITY THAT SHOULD NOT BE FORGOTTEN! NONBACTERIAL THROMBOTIC ENDOCARDITIS (NBTE)

Ruben Montanez - American College of Cardiology (ACC) , 2021

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Nonbacterial thrombotic endocarditis

Hydroxychloroquine

Copyright © 2026. QuantiNova All rights reserved